Neuropsychiatric Issues in Parkinson's Disease.

Loading...
Thumbnail Image

Date

2016-05

Authors

Cooney, Jeffrey W
Stacy, Mark

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

0
views
111
downloads

Citation Stats

Abstract

Cognitive and neuropsychiatric symptoms are common in Parkinson's Disease and may surpass motor symptoms as the major factors impacting patient quality of life. The symptoms may be broadly separated into those associated with the disease process and those that represent adverse effects of treatment. Symptoms attributed to the disease arise from pathologic changes within multiple brain regions and are not restricted to dysfunction in the dopaminergic system. Mood symptoms such as depression, anxiety, and apathy are common and may precede the development of motor symptoms by years, while other neuropsychiatric symptoms such as cognitive impairment, dementia, and psychosis are more common in later stages of the disease. Neuropsychiatric symptoms attributed to treatment include impulse control disorders, pathologic use of dopaminergic medications, and psychosis. This manuscript will review the current understanding of neuropsychiatric symptoms in Parkinson's Disease.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1007/s11910-016-0647-4

Publication Info

Cooney, Jeffrey W, and Mark Stacy (2016). Neuropsychiatric Issues in Parkinson's Disease. Current neurology and neuroscience reports, 16(5). p. 49. 10.1007/s11910-016-0647-4 Retrieved from https://hdl.handle.net/10161/21263.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Cooney

Jeffrey W Cooney

Assistant Professor of Neurology

I see patients with a broad range of movement disorders, including Parkinson's disease, tremors, ataxia, dystonia, tics, and Huntington's disease. I employ deep brain stimulation (DBS) therapy for selected patients with Parkinson's disease, tremor, or dystonia, and use botulinum toxin injections for certain patients with dystonia, tremors, or tics. I work with an interdisciplinary team of physicians, therapists, and other healthcare providers, with the overall goal of helping to improve the lives of patients with complex neurological diseases.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.